Your browser doesn't support javascript.
loading
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.
Abad, A; Martínez-Balibrea, E; Viéitez, J M; Alonso-Orduña, V; García Alfonso, P; Manzano, J L; Massutí, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Grávalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E.
Affiliation
  • Abad A; Medical Oncology Service, Catalan Institute of Oncology, Badalona, Spain.
  • Martínez-Balibrea E; Medical Oncology Service, Catalan Institute of Oncology, Badalona, Spain; Program of Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute, Badalona, Spain; ProCURE (Program Against Cancer Therapeutic Resistance), Catalan Institute of Oncology, Badalona, Sp
  • Viéitez JM; Medical Oncology Service, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Alonso-Orduña V; Medical Oncology Service, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • García Alfonso P; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Manzano JL; Medical Oncology Service, Catalan Institute of Oncology, Badalona, Spain.
  • Massutí B; Medical Oncology Service, Hospital General Universitario de Alicante, Alicante, Spain.
  • Benavides M; Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Málaga, Spain.
  • Carrato A; Ramon y Cajal University Hospital, Ramon y Cajal Institute for Health Research - IRYCIS, Alcala University, CIBERONC, Madrid, Spain.
  • Zanui M; Medical Oncology Service, Hospital de Mataró, Barcelona, Spain.
  • Gallego J; Medical Oncology Service, Hospital General Universitario de Elche, Alicante, Spain.
  • Grávalos C; Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Conde V; Medical Oncology Service, Hospital Virgen de las Nieves, Granada, Spain.
  • Provencio M; Medical Oncology Service, Hospital Puerta de Hierro, Madrid, Spain.
  • Valladares-Ayerbes M; Medical Oncology Service, Complexo Hospitalario Universitario A Coruña, La Coruña, Spain.
  • Salazar R; ONCOBELL program, Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain; Medical Oncology Department, Catalan Institute of Oncology (ICO), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sastre J; Medical Oncology Service, Hospital Clínico San Carlos, Instituto de investigación Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Montagut C; Medical Oncology Service, Hospital del Mar Medical Research Institute, CIBERONC, Barcelona, Spain.
  • Rivera F; Medical Oncology Service, Hospital Marqués de Valdecilla, Santander, Spain.
  • Aranda E; Medical Oncology Service, Instituto Maimónides del Investigación Biomédica de Córdoba (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Ann Oncol ; 29(2): 439-444, 2018 02 01.
Article in En | MEDLINE | ID: mdl-29145602

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymidylate Synthase / Colorectal Neoplasms / DNA-Binding Proteins / Endonucleases / Pharmacogenomic Testing / Pharmacogenomic Variants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymidylate Synthase / Colorectal Neoplasms / DNA-Binding Proteins / Endonucleases / Pharmacogenomic Testing / Pharmacogenomic Variants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: España